C4X Discovery Holdings plc
(“C4XD”, “C4X Discovery” or the “Company”)
Interim results for the six months ended 31 January 2018
12 April 2018 – C4X Discovery Holdings plc (AIM: C4XD), a pioneering drug discovery company, today announces its interim results for the six months ended 31 January 2018.
Deal update
Discovery Engine progress
Innovative technologies to advance drug development
Dr Clive Dix, CEO of C4X Discovery, said: “The recent period has seen C4XD make significant progress towards our goal of becoming the world’s most productive, self-sustaining drug discovery engine. We have strengthened our portfolio of pre-clinical assets aimed at meeting the pharma industry’s increasing demand for high quality early-stage drug candidates and now have a number maturing towards potential out-licensing discussions, with three in particular gaining momentum and commercial interest. The post period completion of the deal with Indivior validates our business model and serves as a solid foundation on which to build towards additional high-value licensing agreements for our portfolio, existing and future.”
1. Source: GBI Research 2012
Analyst conference call today
Clive Dix (Chief Executive Officer), Brad Hoy (Chief Financial Officer) and Craig Fox (Chief Scientific Officer) will present the results at 10:00am BST on 12 April 2018 during a live conference call and webcast. A copy of the final results presentation will be released later this morning on the Company’s website at www.c4xdiscovery.com.
Dial-in details are:
Participant local dial-in: +44 (0)330 336 9411
Participant free phone dial-in: 0800 279 7204
Participant code: 2785155
To access the audio webcast, please follow this link.
An audio replay file will be made available shortly afterwards via the Company website: www.c4xdiscovery.com.
Download the interim financial report below.
This website uses 'cookies' to give you the best most relevant experience. To continue you have to agree to our use of cookies policy and how and why we use cookies.
You can change which cookies are set at any time and find out more about them by reading our privacy policy.